Medicines legislation and regulation in the United Kingdom 1500-2020.
dc.contributor.author | Ferner, Robin | |
dc.contributor.author | Aronson, Jeffrey K | |
dc.date.accessioned | 2023-06-28T12:24:59Z | |
dc.date.available | 2023-06-28T12:24:59Z | |
dc.date.issued | 2022-09-23 | |
dc.identifier.citation | Ferner RE, Aronson JK. Medicines legislation and regulation in the United Kingdom 1500-2020. Br J Clin Pharmacol. 2023 Jan;89(1):80-92. doi: 10.1111/bcp.15497 | en_US |
dc.identifier.eissn | 1365-2125 | |
dc.identifier.doi | 10.1111/bcp.15497 | |
dc.identifier.pmid | 35976677 | |
dc.identifier.uri | http://hdl.handle.net/20.500.14200/1119 | |
dc.description.abstract | The initial purposes of regulation of medicines in England, and latterly in the United Kingdom, were principally to raise government revenue, to discourage murder by poisoning and to regulate the activities of pharmacists. It was only much later that regulators sought to ensure that medicines were of good quality, reasonably safe, and at least somewhat effective, and to curtail misuse of drugs. Here we survey the history of the regulation of medicines and poisons in England from the perspective of clinicians with an interest in therapeutics. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Wiley | en_US |
dc.subject | Clinical pathology | en_US |
dc.title | Medicines legislation and regulation in the United Kingdom 1500-2020. | en_US |
dc.type | Article | |
dc.source.journaltitle | British Journal of Clinical Pharmacology | |
rioxxterms.version | NA | en_US |
dc.contributor.trustauthor | Ferner, Robin | |
dc.contributor.department | West Midlands Centre for Adverse Drug Reactions | en_US |
dc.contributor.role | Medical and Dental | en_US |
dc.contributor.affiliation | University of Birmingham; Sandwell and West Birmingham NHS Trust; University of Oxford | en_US |
oa.grant.openaccess | na | en_US |